Loma Linda University

Enrollment Information
Call us at: 909-558-1000

Faculty Directory
  
Philip Gold, MD
Executive Vice Chair, Medicine
School of Medicine
Professor, Medicine
School of Medicine
Research & Grantsmanship    Funded Research Project (CI)
  • A Phase 2 Study to Evaluate Dose and Duration of Treatment of Drotrecogin Alfa (Activated) Using Serial Measurements of Protein C in Patients with Severe and Multiple Organ Dysfunctions ( 8/2006 - 3/2014 )
  • The effect of a 3-channel electrode array, local heat and hyperbaric oxygen therapy on healing of chronic wounds ( 4/2007 - 7/2008 )
  • A controlled comparison of eritoran tetrasodium and placebo in patients with severe sepsis ( 6/2006 - Present )
  Abstracts Reporting Research -- Non-Peer Reviewed
  • A prospective, randomized, double-blind placebo controlled, dose ranging, multicenter study of the safety and efficacy of three days continuous intravenous infusion of GR270773 in the treatment of suspected or confirmed gram-negative severe sepsis in adults. ( 7/2006 - 6/2008 )
  • A phase 2 randomized, double-blind, placeo-controlled study of the safety and efficacy of talactoferrin alfa in patients with severe sepsis, protocol LF-0801. ( 3/2008 - Present )
  • Protocol #2-001: A randomized double-blind placebo controlled phase-2B study ti assess the safety and efficacy effects of ART-123 on subjects with sepsis and disembinated intravascular coagulation. ( 7/2007 - Present )